Femasys Launches FemaSeed® Complete for OB/GYNs at ACOG 2026

Stock Information for Femasys Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Femasys Inc.

Femasys Drives International Growth with Israeli Market Entry for Fertility Portfolio
Femasys Appoints John Canning as Chief Operating Officer to Drive Operational Execution and Advance Commercial Growth
Femasys Announces Financial Results for Year Ended December 31, 2025 and Provides Corporate Update
Femasys Appoints Dr. Kenneth D. Eichenbaum to Board of Directors
Femasys Advances FemBloc Toward U.S. Approval with Initiation of Pivotal Trial Enrollment
Femasys Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Femasys Announces FemBloc® Permanent Birth Control Has Achieved MDSAP Certification, Advancing Global Market Access
Femasys Receives AMA CPT Editorial Panel Approval for New Category III CPT Code for FemaSeed Intratubal Insemination

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.